PUBLICATIONS · 39102634
Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2-Expressing Biliary Tract Cancer (HERB; NCCH1805): A Multicenter, Single-Arm, Phase II Trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2024 Sep 20
- First author
- Ohba A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- doi: 10.1200/JCO.24.00868
- note
- Source null
- related pmid
- Source null
- relationship
- Comment in
- url
- Source null
Authors and identifiers
- name
- Ohba A
- type
- Author
- name
- Morizane C
- type
- Author
- name
- Kawamoto Y
- type
- Author
- name
- Komatsu Y
- type
- Author
- name
- Ueno M
- type
- Author
- name
- Kobayashi S
- type
- Author
- name
- Ikeda M
- type
- Author
- name
- Sasaki M
- type
- Author
- name
- Furuse J
- type
- Author
- name
- Okano N
- type
- Author
- name
- Hiraoka N
- type
- Author
- name
- Yoshida H
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Ohba A
- type
- Author
- name
- Morizane C
- type
- Author
- name
- Kawamoto Y
- type
- Author
- name
- Komatsu Y
- type
- Author
- name
- Ueno M
- type
- Author
- name
- Kobayashi S
- type
- Author
- name
- Ikeda M
- type
- Author
- name
- Sasaki M
- type
- Author
- name
- Furuse J
- type
- Author
- name
- Okano N
- type
- Author
- name
- Hiraoka N
- type
- Author
- name
- Yoshida H
- type
- Author
- bibliography ids
- nci-bib-49adc88133e18210556e5fdd
- book metadata
- content sha256
- cade2e4d1bc57d57ed3f0139b1cce8a6a4c3e3aeb0e0a184e67383b8b89b05ca
- document type
- citation
- dois
- 10.1200/JCO.23.02010
- electronic publication date
- display
- 2024 Aug 5
- precision
- day
- year
- 2024
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:39102634
- immutable id
- pubmed:39102634@cade2e4d1bc57d57ed3f0139b1cce8a6a4c3e3aeb0e0a184e67383b8b89b05ca
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 27
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3207-3217
- volume
- 42
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- doi: 10.1200/JCO.24.00868
- note
- Source null
- related pmid
- Source null
- relationship
- Comment in
- url
- Source null
- outcomes validated
- false
- pmid
- 39102634
- provenance
- batch id
- 3e43afde6f26fc8df6da
- provider
- NCBI PubMed ESummary
- record sha256
- ed2fa2674ba8f9d0e2fb1ae635a9837ba0a206317d9a34a6434243c947093a3e
- response sha256
- fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
- retrieved at
- 2026-09-09T23:48:21.145285+00:00
- publication date
- display
- 2024 Sep 20
- precision
- day
- year
- 2024
- publication types
- Journal Article
- Clinical Trial, Phase II
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2-Expressing Biliary Tract Cancer (HERB; NCCH1805): A Multicenter, Single-Arm, Phase II Trial.
Preserved source evidence · Not medical advice
Triangle